ReviewSignal transduction and targeted therapy2026
Acute pancreatitis: mechanisms and therapeutic approaches.
Review in Signal transduction and targeted therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Comparative efficacy and safety of Xuesaitong injection as adjuvant therapy for acute pancreatitis: a systematic review and meta-analysis.Frontiers in pharmacology · 2026Pooled it
- miR-215-5p aggravates severe acute pancreatitis by inhibiting SLC7A11 to induce ferroptosis.BMC gastroenterology · 2026Article
- Early non-contrast CT morphology at emergency admission in acute pancreatitis: real-world associations with clinical course.Emergency radiology · 2026Observational
- Review
- Triglyceride Threshold for Intensive Lipid-Lowering Therapy in Acute Hyper-Triglyceridemic Pancreatitis: A Retrospective Study.Journal of clinical medicine · 2026Article
- Neuromodulatory Interventions in Experimental Acute Pancreatitis: A Systematic Review of Rodent Studies.Diseases (Basel, Switzerland) · 2026Review
- Insights into Acute Pancreatitis: Pathogenesis, Diagnosis, and Management.Journal of clinical medicine · 2026Review
- Predicting the Initiation of Continuous Venovenous Hemofiltration in Acute Pancreatitis Patients: The Role of Plasma and Urinary Neutrophil Gelatinase-Associated Lipocalin.Journal of clinical medicine · 2026Article
- Dynamic Assessment of Modified EASIX (m-EASIX) at 48 Hours Predicts Adverse Outcomes in Acute Pancreatitis: A Propensity Score-Matched Study.Medicina (Kaunas, Lithuania) · 2026Article
- Lipemia retinalis secondary to pituitary neuroendocrine tumor: a case report.Frontiers in medicine · 2026Article
- A recurrence prediction model based on serological indicators in children with acute pancreatitis without pancreaticobiliary anatomical abnormalities.Frontiers in pediatrics · 2026Article
- Long non-coding RNA AC245100.4 for early diagnosis and prognostic assessment in acute pancreatitis: clinical value and inflammation-regulatory mechanisms.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Acute pancreatitis is a complex inflammatory condition characterized by sudden onset and rapid progression, with severe cases often associated with high mortality. In recent years, the global incidence of acute pancreatitis has been increasing, with marked regional differences. This increasing trend not only places a considerable burden on healthcare systems but also significantly affects the physical and psychological well-being of patients. The most common causes-gallstone disease, hypertriglyceridemia, and alcohol abuse-also vary by region. This review provides a structured summary of current knowledge regarding the definition and classification of acute pancreatitis, along with recent advances in clinical scoring systems, biomarkers, and predictive models based on artificial intelligence. These tools are particularly valuable for risk stratification and early clinical decision-making. In addition, this review discusses the multilevel pathophysiological mechanisms involved in acute pancreatitis, including aberrant enzymatic activation, calcium overload, impaired autophagy, inflammatory responses, and various forms of pancreatic acinar cell death. From a therapeutic perspective, both early-phase management and strategies for later disease stages are addressed. This review also briefly assesses adjunctive therapies rooted in traditional Chinese medicine, including bioactive monomers, compound herbal formulas, and external treatment modalities. Furthermore, attention is given to individualized treatment approaches for special populations, as well as to emerging therapeutic avenues such as nanotechnology and extracellular vesicle-based interventions. Together, these insights serve as a comprehensive reference for the diagnosis and management of acute pancreatitis while also suggesting potential directions for future research and innovation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.